Leveraging PGx to raise your value proposition in group benefits

If you’ve seen the movie Wall Street, you’ll remember the part when Charlie Sheen confronts the gregarious Wall Street money machine Gordon Gekko (Michael Douglas). Douglas glares at Sheen and says, “OK, pal, tell me something I don’t already know!” Timeless. Let’s talk about pharmacogenetic (PGx) testing, a form...

Precision medicine: a pragmatic addition to your DEI strategy

A recent study found that nearly 75% of employees in underrepresented groups — women, racial and ethnic minorities, and LGBTQ employees — do not feel they've personally benefited from their companies' diversity, equity and inclusion (DEI) programs. As many executives re-examined their organizations' diversity and inclusion initiatives, they discovered a reinvention...

How accurate is pharmacogenetic testing?

Pharmacogenetics uses a patient's genetic profile to accurately predict a drug's efficacy, guide dosage and improve the safety of treatments. Depending on your genetic makeup, some medications may work faster or slower, or produce more or fewer side effects. The scientific field of pharmacogenetics, the link between your unique...

The role of pharmacogenetics for the benefits sponsor community

How COVID is forcing the accelerated evolution of health benefits services and the role of pharmacogenetics in helping plan members get the right medications to support recovery from a wide variety of pandemic-related health issues. Click the image below to read the full article or download the PDF. Benefits And Pensions...

GeneYouIn and Canada Life broaden access to pharmacogenetic testing

Pillcheck preferred retail pricing now available to all Canada Life health insurance customers January 7, 2021, Toronto, ON – GeneYouIn Inc., a leader in personalized medicine, today announced it is growing its relationship with Canada Life, a leading health insurer. The new deal will give preferred retail pricing to all...

Long COVID: Leverage personalized medication optimization to facilitate recovery

As the COVID-19 pandemic unfolds, it is becoming evident that a significant number of people report lasting effects of the infection or have had the usual symptoms for many weeks or even months. Most people recover within two weeks or so, but over 10% of COVID-19 patients remain unwell...

Pillcheck PGx launches new program for benefits advisors on the heels of positive study results in the mental health area

The new program builds on the successful introduction of Pillcheck pharmacogenetics by many insurers seeking to impact the frequency and duration of Short-Term and Long-Term disability claims. Now the same rigorously evaluated, secure service is available to plans and benefit advisors on a subscription basis or as a private...

Do Genetic Tests Belong in Benefit Plans?

Genetic tests can provide predictive insights into many domains, such as ancestry, inherited predisposition to disease or your body’s ability to respond to a certain medication treatment – pharmacogenetics. Veronika Litinski, Pillcheck’s CEO, discusses the benefits for plans and the context for successfully implementing precision medicine with plan members. See...

Pharmacogenetic Testing May Improve Drug Treatments and Shorten Disability

This article in Benefits Quarterly for first quarter 2017 describes how methods of personalized medicine — specifically, pharmacogenetic (PGx) testing— can benefit private health plans, benefits managers, care providers and consumers alike. The authors cover pharmacogenomics as a science and also introduce an innovative way to optimize drug treatments....

Skip to content